Top Industry Leaders in the Epilepsy Devices Market

-
Jan 2023: The closure of Natus Medical Incorporated's acquisition of Micromed Holding SAS, an international supplier of neurophysiology solutions was concluded recently. Natus Medical Incorporated is a leading developer of medical device solutions focusing on detecting, treating, and diagnosing illnesses of the central nervous and sensory systems. The Natus Neuro line will expand to include micromed devices developed in tandem with Natus technology. Customers worldwide will receive incremental value from the goods and organizational experience combined, and this will also create a solid foundation for the creation of new products. Natus has made its first acquisition since delisting from the NASDAQ in July 2022, and it shows that it is committed to making growth-oriented investments.
-
Aug 2023: Leading medical technology company LivaNova PLC announced that its EssenzTM In-Line Blood Monitor (ILBM), which gives perfusionists precise and continuous measurement of vital blood parameters during cardiopulmonary bypass (CPB) procedures, has been cleared by the FDA under 510(k) and has received the CE Mark. With the integration of the ILBM into LivaNova's next-generation CPB platform, the EssenzTM Perfusion System, perfusionists may access and manage dependable blood parameters right from the system's cockpit, negating the need for extra holds or monitors. Perfusionists can receive in-line, ongoing tracking of the patient's parameters during a procedure using the Essenz ILBM. This makes it possible to provide a patient-specific, data-driven approach to perfusion.
List of Epilepsy devices Key companies in the market
-
Charles Rover laboratories (US)
-
Laboratory Corporation of America (US)
-
Intertek (US)
-
Quotient Sciences
-
Reddy’s Laboratories (India)
-
Catalent Inc. (US)
-
Thermo Fischer Scientific Inc. (US)
-
Emergent Biosolutions Inc.(US)
-
Syngene International Limited (India)
-
Irisys LLC Laboratory Corporation of America Holdings (US)